Deal Watch: Teva's Sol Barer Leads Buyout Of IO Start-up NexImmune

 
• By Joseph Haas, Ian Haydock, Ying Huang, John Davis, and Sten Stovall
  
DealWatch_1200x675
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip